Skip to main content
WAVE 2024
Times are shown in your local time zone GMT
Sun Pharma ANZ

Sun Pharma ANZ

NSW

About Sun Pharma ANZ

Sun Pharma is a global leader in pharmaceutical supply and manufacturing, operating in over 100 global markets, with manufacturing sites in over 40 locations around the world. We have a focus on innovative pharmaceutical medicines within the specialty, branded and patent expired medicines segments. Sun Pharma takes prides in upholding our vision of “Reaching People and Touching Lives globally” by providing high-quality, affordable medicines trusted by healthcare professionals and patients.
 
Sun Pharma ANZ has been present in Australia since 2005 through our specialty pharmacy and hospital focused product portfolios. Sun Pharma ANZ has also begun building an Innovator Medical Portfolio with a strong focus in dermatology, ophthalmology, and oncology. It is our mission to treat all patients with compassion, and we strive to provide the best professional committed service to the healthcare professionals who treat them. More recently, Sun Pharma ANZ launched its first product in ophthalmology  – Cequa (ciclosporin 900 microgram/mL)

Sun Pharma ANZ Team

About Us

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over US$ 5.1 billion. Supported by more than 40 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.

In Australia we market pharmaceutical products including a portfolio of branded dermatology products and a range of oral and specialty generics. We also manufacture poppy-derived opiate raw materials that are primarily used in the manufacture of analgesics. All products are manufactured to meet the stringent standards of the Australian Therapeutic Goods Administration.
Globally, our vertically integrated operations including manufacturing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage formulations, together with robust R&D capabilities, enable us to maintain strict control over the quality and cost of our marketed products.
We provide high-quality, affordable medicines trusted by healthcare professionals and patients in over 100 countries of the world. Our global presence is supported by over 40 manufacturing facilities across 5 continents. We have a multi-cultural workforce comprising more than 30,000 employees of over 50 nationalities.



There is NO Exhibitor Codeword here.

Exhibitor Partnerships

The GDPR does not specifically apply to Optometry Australia / Optometry WA as the latter does not have an establishment in the EU nor intentionally engage in targeted marketing to EU individuals specifically. In relation to the management of member data Optometry Australia's current Privacy Act is fully compliant with the respective GDPR data regulations.

We use cookies to ensure you get the best experience on our platform and by continuing to use this site you agree that we can save them on your device. For more information, please read our privacy policy.